Recent Activity

[Research Highlights]Neuron-derived neurotensin and pancreatic cancer-derived semaphorin 3A severe pancreatic cancer and are counteracted by small molecule inhibitors

- 2024-06-28

陳立宗 英文Neuron-derived neurotensin and pancreatic cancer-derived semaphorin 3A severe pancreatic cancer a...
[Research Highlights]RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line therapy: a multicenter study

- 2024-06-28

王照元 圖一英RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line therapy: a mu...
[Research Highlights]A pharmacokinetic analysis in Taiwanese population under tyrosine kinase inhibitors in the treatment of cancer

- 2024-06-28

A pharmacokinetic analysis in Taiwanese population under tyrosine kinase inhibitors in the treatm...
Go to top